Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Company

Belgium Bans Ozempic for Weight Loss as Global Shortage Persists

November 4, 2024
CompanyDeals

Asia Regenerative Medicine Secures Pre-Series A Financing for Bioartificial Organ Development

November 4, 2024
CompanyDrug

CSPC Pharmaceutical’s Glumetinib Earns Breakthrough Therapy Designation in China

November 4, 2024
CompanyMedical Device

AstraZeneca Launches Evinova to Enhance Global Clinical Development with Digital Health Solutions

November 4, 2024
CompanyDrug

BMS and 2seventy Bio’s Abecma Faces FDA Review Extension

November 13, 2024
CompanyDeals

Suzhou Porton Biologics Partners with Asclepius Technology for NK Cell Project

November 4, 2024
Company

Shanghai Pharmaceuticals’ Chairman Zhou Jun Resigns Amid Investigation

November 4, 2024
CompanyDeals

VIVA Biotech Holdings Secures Nearly USD 210 Million in Financing Round

November 4, 2024
CompanyDrug

Jiangsu Aidea Pharmaceutical’s AINUOVIRINE Receives Priority Review Status from CDE

November 4, 2024
CompanyDrug

Medilink Therapeutics’ YL201 Earns Orphan Drug Designation for Esophageal Cancer

November 4, 2024
CompanyDeals

Chiesi Farmaceutici Acquires Global Rights to Haisco Pharmaceutical’s HSK31858 for Respiratory Diseases

November 4, 2024
CompanyDeals

Fosun Pharmaceutical’s US Subsidiary Partners with Treehill Partners for Clinical-Stage Investments

November 4, 2024
1 2 … 7 8 9 10 11 … 25 26
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up